Delivery Order SPE2DX22D0020-SPE2D826F10PM
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $77,111.79 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,109.22 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $45,863.28 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger Indefinite Delivery Contract vehicle and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,443.12 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion targeted for December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $38,190.96 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,620.12 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 15, 2025, with completion expected by December 16, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract arrangement and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor for federal medical procurement. The award utilizes no set-aside designation, reflecting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $63,478.08 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The delivery order will be performed at the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $111,582.57 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-competitive, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $56,274.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 17, 2025, with completion targeted for September 18, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made competitively and supports the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $62,208 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion targeted for December 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award was made through competitive procurement with no set-aside designation, reflecting the contractor's established...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F10PMDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $36,778.53 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price contract, which is not set-aside restricted, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen Drug Corp's established role as a primary pharmaceutical distributor for federal military and veteran healthcare systems. As a major pharmaceutical and medical supply provider, the company fulfills federal procurement requirements for a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The competitive award to AmerisourceBergen demonstrates the company's continued capability to meet federal medical supply standards and support the Defense Health Agency and other government healthcare systems through the DLA's pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.8k | 12/21/25 |